Latest

psilocybin

Brain Cancer Featured Neuroscience Open Neuroscience Articles Psychology

·December 1, 2016·4 min read

Hallucinogenic Psilocybin Offers Relief For Cancer Related Depression and Anxiety

According to researchers, a single large dose if psilocybin, the active hallucinogenic compound found in magic mushrooms, helped provide relief for people suffering from cancer related depression and anxiety for up to six months.

Image shows a Psilocybe “cyanofriscosa” mushroom.

Featured Open Neuroscience Articles Psychology

·May 17, 2016·6 min read

Magic Mushroom Compound May Provide New Avenues for Antidepressant Research

In a new study, researchers report on the potential for using psilocybin, a hallucinogenic compound derived from magic mushrooms, for treating patients with treatment resistant depression.

Image shows Psilocybe allenii mushrooms.

Brain Cancer Featured Neuroscience Psychology

·December 10, 2015·1 min read

Magic Mushroom Component Reduces Depression and Anxiety in Cancer Patients

Study suggests that a single dose of psilocybin, the active ingredient of magic mushrooms, may be enough to produce a lasting decrease in depression and anxiety for cancer patients.

Image shows the shape of a brain made up of words associated with PTSD.

Featured Psychology

·September 8, 2015·1 min read

Renewed Interest in Psychedelics for Treatment of PTSD and Anxiety

According to a new study, psychedelics show some success in treating some psychological disorders.

The image shows a scan which details brain activity under psilocybin.

Featured Neurology Psychology

·July 3, 2014·5 min read

New Study Discovers Biological Basis for Magic Mushroom Mind Expansion

The brain displays a similar pattern of activity during dreaming as it does during a psychedelic trip, a new study reports.

This image shows a psilocybe mexicana mushroom in a field.

Featured Psychology

·May 7, 2014·3 min read

Psilocybin Inhibits the Processing of Negative Emotions in the Brain

A new study reports psilocybin influences the amygdala, weakening the processing of negative stimuli. Researchers hope the finding could pave the way for new treatment approaches for some psychiatric disorders.

Featured Neuroscience

·July 17, 2013·3 min read

Low Doses of Psychedelic Drug Erases Conditioned Fear in Mice

Researchers discover a low dose of psilocybin erased conditioned fear responses in mice. They suggest the agent could be a potential treatment for PTSD and related conditions.